Impact of pharmacist-delivered interventions on pain-related outcomes: An umbrella review of systematic reviews and meta-analyses

Shrestha, Sunil, Iqbal, Ayesha, Teoh, Siew Li, Khanal, Saval ORCID: https://orcid.org/0000-0001-5201-0612, Gan, Siew Hua, Lee, Shaun Wen Huey and Paudyal, Vibhu (2024) Impact of pharmacist-delivered interventions on pain-related outcomes: An umbrella review of systematic reviews and meta-analyses. Research in Social and Administrative Pharmacy, 20 (6). pp. 34-51. ISSN 1551-7411

[thumbnail of Shrestha_etal_2024_RSAP]
Preview
PDF (Shrestha_etal_2024_RSAP)
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Introduction: Pain is a significant healthcare challenge, impacting millions worldwide. Pharmacists have increasingly taken on expanded roles in managing pain, particularly in primary and ambulatory care contexts. This umbrella review aims to systematically evaluate evidence from published systematic reviews that explore the impact of pharmacist-delivered interventions on clinical, humanistic, and economic outcomes related to pain. Methods: A systematic search was conducted across six electronic databases, including Ovid Embase, MEDLINE, CINAHL, Scopus, CENTRAL, APA PsycINFO, and DARE, from inception until June 2023. Prior to inclusion, two independent reviewers assessed study titles and abstracts. Following inclusion, an assessment of the methodological quality of the included studies was conducted. AMSTAR 2 was used to evaluate the methodological quality of the included SRs. Results: From 2055 retrieved titles, 11 systematic reviews were included, with 5 out of 11 being meta-analyses. These SRs encompassed diverse pharmacist-led interventions such as education, medication reviews, and multi-component strategies targeting various facets of pain management. These findings showed favorable clinical outcomes, including reduced pain intensity, improved medication management, enhanced overall physical and mental well-being, and reduced hospitalization durations. Significant pain intensity reductions were found due to pharmacists' interventions, with standardized mean differences (SMDs) ranging from −0.76 to −0.22 across different studies and subgroups. Physical functioning improvements were observed, with SMDs ranging from −0.38 to 1.03. Positive humanistic outcomes were also reported, such as increased healthcare provider confidence, patient satisfaction, and quality of life (QoL). QoL improvements were reported, with SMDs ranging from 0.29 to 1.03. Three systematic reviews examined pharmacist interventions’ impact on pain-related economic outcomes, highlighting varying cost implications and the need for robust research methodologies to capture costs and benefits. Conclusion: This umbrella review highlights the effectiveness of pharmacist-delivered interventions in improving clinical, humanistic, and economic outcomes related to pain management. Existing evidence emphasises on the need to integrate pharamacists into multi-disciplinary pain management teams. Further research is needed to investigate innovative care models, such as pharmacist-independent prescribing initiatives within collaborative pain management clinics.

Item Type: Article
Uncontrolled Keywords: cancer pain,pharmaceutical services,pharmacist,umbrella review,pharmacy,pharmaceutical science ,/dk/atira/pure/subjectarea/asjc/3600/3611
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 25 Mar 2024 14:31
Last Modified: 21 May 2024 16:30
URI: https://ueaeprints.uea.ac.uk/id/eprint/94751
DOI: 10.1016/j.sapharm.2024.03.005

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item